Chickenpox pathophysiology

Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]

Chickenpox Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chickenpox from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chickenpox pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chickenpox pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chickenpox pathophysiology

CDC on Chickenpox pathophysiology

Chickenpox pathophysiology in the news

Blogs on Chickenpox pathophysiology

Directions to Hospitals Treating Chickenpox

Risk calculators and risk factors for Chickenpox pathophysiology

Overview

Chickenpox is a highly contagious disease contracted by the inhalation of aerosolized nasopharyngeal secretions droplets or through direct contact with the vesicles from an infected host. It takes from 10 to 21 days after exposure to a person with chickenpox or shingles for someone to develop chickenpox. Viral proliferation occurs in regional lymph nodes of the upper respiratory tract leading to viremia. Viremia is characterized by diffuse viral invasion of capillary endothelial cells and the epidermis. VZV infection of cells of the malpighian layer produces both intercellular and intracellular edema, resulting in the characteristic vesicle.

Pathophysiology

Chickenpox is contracted by the inhalation of aerosolized nasopharyngeal secretions droplets from an infected host. The highly contagious nature of VZV explains the epidemics of chickenpox that spread through schools as one child who is infected quickly spreads the virus to many classmates. High viral titers are found in the vesicles of chickenpox; hence, the viral transmission may also occur through direct contact with these vesicles and the risk is lower comparatively.

Transmission

  • The virus spreads easily from people with chickenpox to others who have never had the disease or received the chickenpox vaccine. The virus spreads in the air when an infected person coughs or sneezes. It can also be spread by touching or breathing in the virus particles that come from chickenpox blisters.
  • Chickenpox can also be spread from people with shingles. Varicella-zoster virus also causes shingles. A person with shingles can spread the virus to others who have never had chickenpox or received the chickenpox vaccine. In these cases, the exposed person might develop chickenpox.
  • A person with chickenpox can spread the disease from 1 to 2 days before they get the rash until all their chickenpox blisters have formed scabs.
  • If a person vaccinated for chickenpox gets the disease, they can still spread it to others.
  • For most people, getting chickenpox once provides immunity for life. However, for a few people, they can get chickenpox more than once, although this is not common.
  • Nosocomial transmission of Varicella-zoster virus (VZV) is well-recognized and can be life threatening to certain groups of patients. Reports of nosocomial transmission are relatively uncommon in the United States since introduction of varicella vaccine.

Incubation Period

  • It takes from 10 to 21 days after exposure to a person with chickenpox or shingles for someone to develop chickenpox.

Dissemination

  • After initial inhalation of contaminated aerosolized droplets, the virus infects the conjunctivae or the mucosae of the upper respiratory tract. Viral proliferation occurs in regional lymph nodes of the upper respiratory tract 2-4 days after initial infection and is followed by primary viremia on postinfection days 4-6.

Pathogenesis

  • A second round of viral replication occurs in the body's internal organs, most notably the liver and the spleen, followed by a secondary viremia 14-16 days postinfection. This secondary viremia is characterized by diffuse viral invasion of capillary endothelial cells and the epidermis. VZV infection of cells of the malpighian layer produces both intercellular and intracellular edema, resulting in the characteristic vesicle.
  • Reactivation of VZV results in the clinically distinct syndrome of herpes zoster (shingles).

Genetics

  • There is no genetic predisposition associated with the disease chickenpox. However, regarding varicella vaccination, similarities in siblings' response to varicella vaccine are supportive of the hypothesis that genetic factors play a role in the antibody response to the varicella vaccine. [1]

Associated Conditions

Conditions associated with chickenpox are:

  • Fever
  • Rash
  • Pruritis
  • Lymph node enlargement

Gross Pathology

  • There area no gross pathological findings findings observed in chickenpox. In varicella pneumonia, calcifications are observed in the lungs. [2]

Microscopic Pathology

References

  1. Klein NP, Fireman B, Enright A, Ray P, Black S, Dekker CL (2007). "A role for genetics in the immune response to the varicella vaccine". Pediatr. Infect. Dis. J. 26 (4): 300–5. doi:10.1097/01.inf.0000257454.74513.07. PMID 17414391.
  2. Raider L (1971). "Calcification in chickenpox pneumonia". Chest. 60 (5): 504–7. PMID 5119892.
  3. "Home - Public Health Image Library (PHIL)".
  4. 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 "Public Health Image Library (PHIL)".


Template:WikiDoc Sources